Fluoxetine increases the anorectic and long-term dopamine-depleting effects of phentermine

Synapse

Volumn 38, Issue 4, 2000, Pages 471-476

  Callahan, Brian T ^a   Yuan, Jie ^a   Ricaurte, George A ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Anorexia; Dopamine; Fluoxetine; Neurotoxicity; Phentermine; Weight loss

Indexed keywords

AMPHETAMINE DERIVATIVE; DOPAMINE; FENFLURAMINE; FLUOXETINE; MIXED FUNCTION OXIDASE; PHENTERMINE; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANOREXIA; ARTICLE; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; DRUG BRAIN LEVEL; DRUG DEGRADATION; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; ENZYME INHIBITION; FOOD DEPRIVATION; MALE; MOUSE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; SEROTONIN UPTAKE; WEIGHT REDUCTION;

ANIMALS; ANOREXIA; APPETITE DEPRESSANTS; BIOGENIC MONOAMINES; BODY TEMPERATURE; BODY WEIGHT; BRAIN; DOPAMINE ANTAGONISTS; EATING; FLUOXETINE; LIVER; MALE; MICE; OXIDOREDUCTASES; PHENTERMINE; TIME FACTORS;

EID: 0034672789     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/1098-2396(20001215)38:4<471::AID-SYN12>3.0.CO;2-6     Document Type: Article

References (27)

1. Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: Pharmacological profile of protective and nonprotective agents
2. Low environmental temperatures or pharmacologic agents that produce hypothermia decrease methamphetamine neurotoxicity in mice
3. Effects of phentermine on striatal dopamine and serotonin release in conscious rats: In vivo microdialysis study
4. Dexfenfluramine and neurotoxicity
5. The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in striatum
6. Further studies of the role of hyperthermia in methamphetamine neurotoxicity
7. 14C]methamphetamine in man, the guinea and the rat
8. In search of a 'magic' pill to treat obesity: The rise and fall of 'Fen-Phen'
9. Inhibition of drug metabolism by fluoxetine
10. Fluoxetine at anorectic doses does not have properties of a dopamine uptake inhibitor
11. Interaction of phentermine plus fenfluramine: Neurochemical and neurotoxic effects
12. Microdialysis studies of brain norepinephrine, serotonin, and dopamine release during ingestive behavior. Theoretical and clinical implications
13. Evaluation of potential neurotoxic effects of amphetamine-related anorectic agents on brain dopamine and serotonin in the rat
14. Molecular basis and clinical consequences of genetic cytochrome P450 2D6 polymorphism
15. Combined phentermine/fenfluramine administration enhances depletion of serotonin from central terminal fields
16. Neurotoxic effects of (+/-) fenfluramine and phentermine, alone and in combination, on monoamine neurons in the mouse brain
17. Environment-, drug-, and stress-induced alterations in body temperature affect the neurotoxicity of substituted amphetamines in the C57BL/6J mouse
18. Metabolism of mephentermine in male guinea pigs and male mice
19. Metabolism of phentermine and its derivatives in the male Winstar rat
20. Newer antidepressants and the cytochrome P450 system
21. Effects of a single dose of methamphetamine and iprindole on the serotonergic and dopaminergic system of the rat brain
22. Fluoxetine increases long-lasting neostriatal dopamine depletion after administration of d-methamphetamine and d-amphetamine
23. Lasting effects of (±)3,4-methylenedioxymethamphetamine on central serotonergic neurons in non-human primates: Neurochemical observations
24. Efficacy of administration of dexfenfluramine and phentermine, alone and in combination, on ingestive behavior and body weight in rats
25. The effect of selective lesioning of brain catecholamine-containing neurons on the activity of various anorectics in the rat
26. A double-blind clinical trial in weight control. Use of fenfluramine and phentermine alone and in combination
27. Long-term weight control study. I (weeks 0 to 34). The enhancement of behavior modification, caloric restriction, and exercise by fenfluramine plus phentermine versus placebo